United States · FDA National Drug Code directory
MIMRYLO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63020-745_2fc41c37-8a81-4171-a52c-e9317c0c34cf
- Product NDC
- 63020-745
- Form
- KIT
- Composition / generic term
- rusfertide
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20260828
- Source listing expiry
- 20271231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 1 KIT in 1 CARTON (63020-745-40) * 41 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (63020-740-40) * .6 mL in 1 SYRINGE (63020-600-05) · 63020-745-40
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →